Journal of Periodontal and Implant Science

Korean Academy of Periodontology (대한치주과학회)
권호 표지

The Expression of RANK and RANKL in Gingival Tissue of Human Chronic Periodontitis

만성 치주염 환자의 치은 조직에서 RANK 및 RANKL의 발현

  • Baek, Young-Ran (Department of Periodontology, School of Dentistry, Kyungpook National University) ;
  • Lee, Jae-Mok (Department of Periodontology, School of Dentistry, Kyungpook National University)
  • 백영란 (경북대학교 치의학전문대학원 치주과학교실) ;
  • 이재목 (경북대학교 치의학전문대학원 치주과학교실)
  • Published : 2007.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The purposes of this study were to compare and quantify the expressions of RANK and RANKL in the gingival tissues of non-periodontitis patient and patients with chronic periodontitis, in order to understand the contribution of these proteins to periodontal destruction. Material and methods: Gingival tissue samples were obtained during periodontal surgery or tooth extraction. According to the patient's systemic condition & clinical criteria of gingiva, each gingival sample was divided into two groups. Group 1 (n=8) is clinically healthy gingiva without bleeding and no evidence of bone resorption or periodontal pockets, obtained from non-periodontitis patients. Group 2 (n=8) is inflammed gingiva from patients with chronic periodontitis. Tissue samples were prepared and analyzed by Western blotting. The quantification of RANK and RANKL were performed using a densitometer and statistically analyzed by Student's t-Test. Results: The expression of RANK were similar in group 1 and 2. The difference between group 1 and 2 was not statistically significant. And the mean amount of RANKL was more increased in group 2 than group 1. The difference between group 1 and group 2 was statistically significant. Conclusion: The expression level RANK didn't show any significant difference between healthy tissue from non-periodontitis patients and inflamed tissue from chronic periodontitis, but the expression level of RANKL in inflammed tissue from chronic periodontitis showed significantly increased tendency compared to healthy gingiva from non-periodontitis patients. Therefore, characteristics of RANK and RANKL in progress of chronic periodontitis would be basis of further studies in diagnostic method and treatment index of the disease.

Keywords

References

  1. Ishikawa I, Nakashima K, Koseki T et al, Induction of the immune response to periodontopathic bacteria and its role in the pathogenesis of periodontitis. Periodontol 2000, 1997;14:79-111 https://doi.org/10.1111/j.1600-0757.1997.tb00193.x
  2. Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med 2001;79:243-53 https://doi.org/10.1007/s001090100226
  3. Yasuda H, Shima N, Nakagawa N et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis- inhibitory factor and is identical to TRANCE/ RANKL. Proc Natl Acad Sci U S A. 1998;95: 3597-602 https://doi.org/10.1073/pnas.95.7.3597
  4. Quinn JMW, Horwood NJ, Elliott J, Gillespie MT, Martin TJ. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation, J Bone Miner Res 2000;15(8): 1459-66 https://doi.org/10.1359/jbmr.2000.15.8.1459
  5. Taubman MA, Kawai T, Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med 2001;12:125-35 https://doi.org/10.1177/10454411010120020301
  6. Kanamaru F, Iwai H, Ikeda T, Nakajima A, Ishikawa I, Azuma, Expression of membrane- bound and soluble receptor activator of NF-kappaB ligand (RANKL) in human T cells. Immunol Lett 2004;94:239-46 https://doi.org/10.1016/j.imlet.2004.05.010
  7. Katagiri T, Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 2002;8:147-59 https://doi.org/10.1034/j.1601-0825.2002.01829.x
  8. Wada T, Nakashima T, Hiroshi N, Penninger JM. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 2006;12:17-25 https://doi.org/10.1016/j.molmed.2005.11.007
  9. Hofbauer LC, Khosla S, Dunstan CR et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000;15:2-12 https://doi.org/10.1359/jbmr.2000.15.1.2
  10. Hsu H, Lacey DL, Dunstan CR et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A 1999;96:3540-5 https://doi.org/10.1073/pnas.96.7.3540
  11. Yasuda H, Shima N, Nakagawa N et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998;139:1329-37 https://doi.org/10.1210/en.139.3.1329
  12. Hormdee D, Nagasawa T, Kiji M. Protein kinase-A-dependent osteoprotegerin production on interleukin-1 stimulation in human gingival fibroblasts is distinct from periodontal ligament fibroblasts. Clin Exp Immunol 2005;142:490-7
  13. Mizuno N, Shiba H, Mouri Y et al. Characterization of epithelial cells derived from periodontal ligament by gene expression patterns of bone-related and enamel proteins. Cell Biol Int 2005;29:111-7 https://doi.org/10.1016/j.cellbi.2004.11.012
  14. Nagasawa T, Kiji M, Yashiro R et al. Roles of receptor activator of nuclear factor- kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease. Periodontol 2000. 2007;43:65-84. Review https://doi.org/10.1111/j.1600-0757.2006.00185.x
  15. Sakata M, Shiba H, Komatsuzawa H et al. Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells. J Bone Miner Res 1999;14:1486-92 https://doi.org/10.1359/jbmr.1999.14.9.1486
  16. Teng YT, Nguyen H, Gao X et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 2000;106:R59-67 https://doi.org/10.1172/JCI10763
  17. Ogasawara T, Yoshimine Y, Kiyoshima T et al. In situ expression of RANKL, RANK, osteoprotegerin and cytokines in osteoclasts of rat periodontal tissue. J Periodontal Res 2004;39:42-9 https://doi.org/10.1111/j.1600-0765.2004.00699.x
  18. Muhlemann HR and Son S. Gingival sulcus bleeding a leading symptom in initial gingivitis. Helv Odontol Acta 1971;15:107
  19. Amitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6 https://doi.org/10.1902/annals.1999.4.1.1
  20. Kang MG, Cha HG, Song SH et al. MMP-2, MMP-8 Expression in gingival tissue of chronic periodontitis associated to Type 2 Diabetes Mellitus. Journal of Korean Academy of Periodontology 2005;35:661-674
  21. Cho JY, Xing S, Liu X et al. Expression and activity of human Na+/I-symporterinhumangliomacellsbyadenovirus- mediatedg enedelivary. GeneTherapy 2000;7:740-749
  22. Choi BK, Moon SY, Cha JH, Kim KW, Yoo YJ. Prostaglandin E2 is a main mediator in receptor activator of nuclear factor-kB ligand- dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii. J Periodontol 2005;76:813-820 https://doi.org/10.1902/jop.2005.76.5.813
  23. Bickel M, Axtelius B, Solioz C, Attstrom R. Cytokine gene expression in chronic periodontitis. J Clin Periodontol 2001;28(9): 840-7 https://doi.org/10.1034/j.1600-051x.2001.028009840.x
  24. Ishihara Y, Nishihara T, Kuroyanagi T et al. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodontal Res 1990;32:524-9 https://doi.org/10.1111/j.1600-0765.1997.tb00568.x
  25. Crotti T, Smith MD, Hirsch R et al. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res 2003;38:380-7 https://doi.org/10.1034/j.1600-0765.2003.00615.x
  26. Theoleyre S, Wittrant Y, Tat SK et al. The molecular triad OPG/RANK/RANKL: in volvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 2004;15:457-75 https://doi.org/10.1016/j.cytogfr.2004.06.004
  27. Nagasawa T, Kobayashi H, Kiji M et al. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. Clin Exp Immunol 2002; 130:338-44 https://doi.org/10.1046/j.1365-2249.2002.01990.x
  28. Liu D, Xu JK, Figliomeni L et al. Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Int J Mol Med 2003;11: 17-21
  29. Mogi M, Otogoto J, Ota N, Togari A. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 2004;83:166-9 https://doi.org/10.1177/154405910408300216
  30. Bostanci N, Ilgenli T, Emingil G et al. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol 2007;34:370-6 https://doi.org/10.1111/j.1600-051X.2007.01061.x
  31. Bostanci N, Ilgenli T, Emingil G et al. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases. J Periodontal Res 2007;42:287-93 https://doi.org/10.1111/j.1600-0765.2006.00946.x
  32. Okahashi N, Inaba H, Nakagawa I et al. Porphyromonas gingivalis induces receptor activator of NF-kappaB ligand expression in osteoblasts through the activator protein 1 pathway. Infect Immun 2004;72:1706-14 https://doi.org/10.1128/IAI.72.3.1706-1714.2004
  33. Belibasakis GN, Johansson A, Wang Y et al. Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin. Cytokine 2005;30:56-63 https://doi.org/10.1016/j.cyto.2004.11.008
  34. Kikuchi T, Matsuguchi T, Tsuboi N et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J Immunol 2001;166:3574-9 https://doi.org/10.4049/jimmunol.166.5.3574
  35. Kawai T, Matsuyama T, Hosokawa Y et al. Band T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 2006; 169:987-98 https://doi.org/10.2353/ajpath.2006.060180
  36. Huang JC, Sakata T, Pfleger LL et al. PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 2004; 19:235-44 https://doi.org/10.1359/JBMR.0301226
  37. Tsukii K, Shima N, Mochizuki S et al. Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha, 25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. Biochem Biophys Res Commun. 1998;246:337-41 https://doi.org/10.1006/bbrc.1998.8610